
Post ESMO Webinar
CECOG Academy
Adjuvant Therapies for HER2+ eBC: Trastuzumab & Pertuzumab, T-DM1 & T-Dxd Clinical Trial Overview
FEATURING
Christian Singer
- 50 views
- April 1, 2021
CECOG Academy
New Adjuvant Therapies for eBC: Olaparib & Talazoparib for BRCA Mutations
FEATURING
Christian Singer
- 103 views
- April 1, 2021
CECOG Academy
How to Increase the Efficacy of Antiendocrine Treatment of BC: Options and Limitations
FEATURING
Peter Fasching
- 45 views
- March 29, 2021
CECOG Academy
Immune Checkpoint Inhibition in mBC: Does the Chemotherapy Backbone Matter?
FEATURING
Rupert Bartsch
- 6 views
- March 29, 2021